Research ExplorerPublicationsReal-Life comparison of pegylated-interferon 2a versus 2b co...

Real-Life comparison of pegylated-interferon 2a versus 2b combination therapy of chronic hepatitis C virus.

Standard

Real-Life comparison of pegylated-interferon 2a versus 2b combination therapy of chronic hepatitis C virus. / Schulze Zur Wiesch, Julian; Pudelski, Neele; Hoepner, Lena; Supplieth, Michael; Buggisch, Peter; Lohse, Ansgar W.; Lüth, Stefan.

In: HEPATOLOGY, Vol. 53, No. 4, 4, 2011, p. 1405-1407.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Schulze Zur Wiesch, J, Pudelski, N, Hoepner, L, Supplieth, M, Buggisch, P, Lohse, AW & Lüth, S 2011, 'Real-Life comparison of pegylated-interferon 2a versus 2b combination therapy of chronic hepatitis C virus.', HEPATOLOGY, vol. 53, no. 4, 4, pp. 1405-1407. <http://www.ncbi.nlm.nih.gov/pubmed/21480360?dopt=Citation>

APA

Schulze Zur Wiesch, J., Pudelski, N., Hoepner, L., Supplieth, M., Buggisch, P., Lohse, A. W., & Lüth, S. (2011). Real-Life comparison of pegylated-interferon 2a versus 2b combination therapy of chronic hepatitis C virus. HEPATOLOGY, 53(4), 1405-1407. [4]. http://www.ncbi.nlm.nih.gov/pubmed/21480360?dopt=Citation

Vancouver

Schulze Zur Wiesch J, Pudelski N, Hoepner L, Supplieth M, Buggisch P, Lohse AW et al. Real-Life comparison of pegylated-interferon 2a versus 2b combination therapy of chronic hepatitis C virus. HEPATOLOGY. 2011;53(4):1405-1407. 4.

Bibtex

@article{46e78fa3788c47b18f7a9f56f03ec889,
title = "Real-Life comparison of pegylated-interferon 2a versus 2b combination therapy of chronic hepatitis C virus.",
keywords = "Adult, Humans, Male, Aged, Female, Middle Aged, Adolescent, Antiviral Agents/*therapeutic use, Hepatitis C, Chronic/*drug therapy/virology, Interferon-alpha/*therapeutic use, Polyethylene Glycols/*therapeutic use, Randomized Controlled Trials as Topic/methods, Recombinant Proteins, Ribavirin/therapeutic use, Adult, Humans, Male, Aged, Female, Middle Aged, Adolescent, Antiviral Agents/*therapeutic use, Hepatitis C, Chronic/*drug therapy/virology, Interferon-alpha/*therapeutic use, Polyethylene Glycols/*therapeutic use, Randomized Controlled Trials as Topic/methods, Recombinant Proteins, Ribavirin/therapeutic use",
author = "{Schulze Zur Wiesch}, Julian and Neele Pudelski and Lena Hoepner and Michael Supplieth and Peter Buggisch and Lohse, {Ansgar W.} and Stefan L{\"u}th",
year = "2011",
language = "English",
volume = "53",
pages = "1405--1407",
journal = "HEPATOLOGY",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

RIS

TY - JOUR

T1 - Real-Life comparison of pegylated-interferon 2a versus 2b combination therapy of chronic hepatitis C virus.

AU - Schulze Zur Wiesch, Julian

AU - Pudelski, Neele

AU - Hoepner, Lena

AU - Supplieth, Michael

AU - Buggisch, Peter

AU - Lohse, Ansgar W.

AU - Lüth, Stefan

PY - 2011

Y1 - 2011

KW - Adult

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Adolescent

KW - Antiviral Agents/therapeutic use

KW - Hepatitis C, Chronic/drug therapy/virology

KW - Interferon-alpha/therapeutic use

KW - Polyethylene Glycols/therapeutic use

KW - Randomized Controlled Trials as Topic/methods

KW - Recombinant Proteins

KW - Ribavirin/therapeutic use

KW - Adult

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Adolescent

KW - Antiviral Agents/therapeutic use

KW - Hepatitis C, Chronic/drug therapy/virology

KW - Interferon-alpha/therapeutic use

KW - Polyethylene Glycols/therapeutic use

KW - Randomized Controlled Trials as Topic/methods

KW - Recombinant Proteins

KW - Ribavirin/therapeutic use

M3 - SCORING: Journal article

VL - 53

SP - 1405

EP - 1407

JO - HEPATOLOGY

JF - HEPATOLOGY

SN - 0270-9139

IS - 4

M1 - 4

ER -